NAMS
NASDAQ · Biotechnology
Newamsterdam Pharma Co Nv
$18.90
+0.01 (+0.05%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
+92.5% upside
Low Target
$23.00
Average Target
$36.39
High Target
$47.36
Current Price
$18.90
Current
$18.90
$18.90
Target
$36.39
$36.39
$23.00
$36.39 avg
$47.36
Scenario Analysis
Bear Case
$23.00
21.7%
Low target
Base Case
$36.39
+92.5%
Avg target
Bull Case
$47.36
+150.6%
High target
Risk/Reward
6.9x
Highly favorable
Price in Context
52-Week High
$42.21
-55.2% from high
52-Week Low
$18.86
+0.2% from low
50-Day SMA
$22.10
-14.5% vs SMA
200-Day SMA
$29.47
-35.9% vs SMA
RSI (14)
41.9
Neutral
Target vs 52W High
$36.39
-13.8% vs high
Next Earnings Report
Nov 11, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.52
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |